Urology
Volume 77, Issue 1 , Pages 5-11 , January 2011

Acute Kidney Injury: Novel Biomarkers and Potential Utility for Patient Care in Urology

Received 25 April 2010 ,Accepted 1 May 2010.

References 

  1. Bellomo R, et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212
  2. Mehta RL, et al. Acute Kidney Injury Network Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31
  3. Kellum JA, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care. 2002;8(6):509–514
  4. Metcalfe W, et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM. 2002;95(9):579–583
  5. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39(5):930–936
  6. Uchino S, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818
  7. Chertow GM, et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int. 2006;70(6):1120–1126
  8. Hoste EA, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73
  9. Lassnigg A, et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004;15(6):1597–1605
  10. Ishani A, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009;20(1):223–228
  11. Clarkson MR, F.J., Eustace JA, et al. Brenner and Rector's The Kidney. 8th ed. Philadelphia: Saunders Elsevier, :943-975.
  12. Fischer MJ, et al. Uncomplicated acute renal failure and hospital resource utilization: a retrospective multicenter analysis. Am J Kidney Dis. 2005;46(6):1049–1057
  13. Molitoris BA, et al. Technology insight: biomarker development in acute kidney injury—what can we anticipate?. Nat Clin Pract Nephrol. 2008;4(3):154–165
  14. Allgren RL, et al. Anaritide in acute tubular necrosis (Auriculin Anaritide Acute Renal Failure Study Group). N Engl J Med. 1997;336(12):828–834
  15. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet. 2005;365(9457):417–430
  16. Star RA. Treatment of acute renal failure. Kidney Int. 1998;54(6):1817–1831
  17. Parikh CR, Devarajan P. New biomarkers of acute kidney injury. Crit Care Med. 2008;36(4):S159–S165
  18. Soni SS, et al. Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif. 2009;28(3):165–174
  19. Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;241:89–94
  20. Araki M, et al. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation. 2006;81(5):783–788
  21. Hudkins KL, et al. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol. 1999;10(3):444–457
  22. Trof RJ, et al. Biomarkers of acute renal injury and renal failure. Shock. 2006;26(3):245–253
  23. Borregaard N, Cowland JB. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biol Met. 2006;19(2):211–215
  24. Devarajan P, et al. Gene expression in early ischemic renal injury: clues towards pathogenesis, biomarker discovery, and novel therapeutics. Mol Genet Metab. 2003;80(4):365–376
  25. Mishra J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14(10):2534–2543
  26. Mori K, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005;115(3):610–621
  27. Mishra J, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238
  28. Wagener G, et al. Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology. 2006;105(3):485–491
  29. Mishra J, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21(6):856–863
  30. Parikh CR, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6(7):1639–1645
  31. Parikh CR, et al. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2006;70(1):199–203
  32. Parikh CR, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis. 2004;43(3):405–414
  33. Lane BR, et al. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol. 2009;182(2):435–443[Discussion:443-444]
  34. Herget-Rosenthal S, et al. Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004;66(3):1115–1122
  35. Koyner JL, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008;74(8):1059–1069
  36. Herget-Rosenthal S, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem. 2004;50(3):552–558
  37. Villa P, et al. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients. Crit Care. 2005;9(2):R139–R143
  38. Ichimura T, et al. Kidney injury molecule 1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273(7):4135–4142
  39. Han WK, et al. Kidney injury molecule 1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62(1):237–244
  40. Han WK, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73(7):863–869
  41. Liangos O, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers. 2009;14(6):423–431
  42. Thakar CV, et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol. 2005;16(1):162–168
  43. Palomba H, et al. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int. 2007;72(5):624–631
  44. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol. 2001;166(1):6–18
  45. Gill IS, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178(1):41–46
  46. Lane BR, et al. Factors predicting renal functional outcome after partial nephrectomy. J Urol. 2008;180(6):2363–2368[Discussion:2368-2369]
  47. Fergany AF, et al. Open partial nephrectomy for tumor in a solitary kidney: experience with 400 cases. J Urol. 2006;175(5):1630–1633[Discussion:1633]
  48. Nguyen MM, Gill IS. Halving ischemia time during laparoscopic partial nephrectomy. J Urol. 2008;179(2):627–632[Discussion:632]
  49. Chiao H, et al. Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest. 1997;99(6):1165–1172
  50. Aravindan N, et al. Effect of fenoldopam on ischemia/reperfusion-induced apoptosis. Ren Fail. 2006;28(4):337–344

PII: S0090-4295(10)00653-9

doi: 10.1016/j.urology.2010.05.004

Urology
Volume 77, Issue 1 , Pages 5-11 , January 2011

Article Tools